Bulletin
Investor Alert

Takeda Pharmaceutical Co. Ltd.

TKS: JP:4502

GO
/marketstate/country/jp

Market closed

/zigman2/quotes/201302442/delayed

¥

4,134.00

Change

-42.00 -1.01%

Volume

Volume 4.03m

Jan 27, 2023, 3:00 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201302442/delayed

Previous close

¥ 4,176.00

¥ 4,134.00

Change

-42.00 -1.01%

Day low

Day high

¥4,118

¥4,175

Open
Open: 4,163.00

52 week low

52 week high

¥3,250

¥4,238

Open

Market cap

¥6568.30B

Average volume

4.69M

P/E ratio

30.30

Rev. per Employee

¥79.19M

EPS

136.42

Dividend

90.00

Div yield

4.35%

Ex dividend date

3/30/23

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/jp/4502

MarketWatch News on 4502

  1. Takeda inks deal with Hutchmed for up to $1.1 billion

    8:31 a.m. Jan. 23, 2023

    - Jaimy Lee

  2. Japan approves Novavax as fourth COVID-19 vaccine amid new surge

    10:26 p.m. April 19, 2022

    - Associated Press

  3. Blackstone to acquire Takeda's consumer health care business for $2.3 bln: WSJ

    6:42 a.m. Aug. 24, 2020

    - Ciara Linnane

  4. Asian markets pull back ahead of Trump-Xi meeting at G-20

    12:03 a.m. June 25, 2019

    - Marketwatch

  5. Asian markets mostly rise, following Wall Street’s lead

    10:45 p.m. May 14, 2019

    - Marketwatch

  6. Asian markets rise as Trump, Kim set to meet

    8:54 a.m. Feb. 27, 2019

    - Associated Press

  7. Loading more headlines...
/news/nonmarketwatch/company/jp/4502

Other News on 4502

  1. T. Rowe Price Japan Fund Buys 1, Sells 4 in 4th Quarter

    6:00 p.m. Jan. 16, 2023

    - GuruFocus.com

  2. Top 5 3rd Quarter Trades of T. Rowe Price Japan Fund

    12:00 p.m. Oct. 17, 2022

    - GuruFocus.com

  3. Orexigen Terminates Required Study for Diet Drug Contrave

    11:57 a.m. May 12, 2015

    - The Wall Street Journal Interactive Edition

  4. Takeda Pharmaceutical to Pay $2.4 Billion to Settle Lawsuits

    8:52 a.m. April 29, 2015

    - The Wall Street Journal Interactive Edition

  5. Merck’s Revenue Doesn’t Fit Its Stock

    7:07 p.m. April 28, 2015

    - The Wall Street Journal Interactive Edition

  6. Amgen Sees Positive Results From Kyprolis Study

    12:28 a.m. March 2, 2015

    - The Wall Street Journal Interactive Edition

  7. Valeant to Buy Salix for About $10 Billion

    8:44 p.m. Feb. 23, 2015

    - The Wall Street Journal Interactive Edition

  8. Parents Struggle to Cure Loved Ones, and Make Money

    2:27 p.m. Dec. 27, 2014

    - The Wall Street Journal Interactive Edition

  9. A Japan ETF That Capitalizes on Abenomics

    2:32 a.m. Jan. 5, 2015

    - The Wall Street Journal Interactive Edition

  10. Abilify Maker Otsuka to Buy Avanir

    2:37 a.m. Dec. 31, 2014

    - The Wall Street Journal Interactive Edition

  11. Corporate Watch: News Digest

    8:30 p.m. Oct. 27, 2014

    - The Wall Street Journal Interactive Edition

  12. Judge Cuts Damages Takeda, Lilly to Pay in Actos Case

    9:44 p.m. Oct. 27, 2014

    - The Wall Street Journal Interactive Edition

  13. FDA Approves Weight-Loss Drug

    11:51 a.m. Sept. 11, 2014

    - The Wall Street Journal Interactive Edition

  14. How Doctor Got Rich Invoking Antifraud Law

    10:39 a.m. July 24, 2014

    - The Wall Street Journal Interactive Edition

  15. Corrections & Amplifications

    1:34 a.m. Aug. 13, 2014

    - The Wall Street Journal Interactive Edition

  16. Alzheimer's Disease Fight Focuses on Preventive Treatment

    1:32 a.m. Aug. 12, 2014

    - The Wall Street Journal Interactive Edition

  17. Japan Prosecutors Charge Novartis Unit Over Research

    8:11 p.m. July 1, 2014

    - The Wall Street Journal Interactive Edition

  18. Loading more headlines...

Rates »

Link to MarketWatch's Slice.